Affiliation:
1. Department of Cell Biology & Neuroscience, 1113 Biological Sciences Building, University of California Riverside, Riverside, CA 92521, USA
Abstract
As the worldwide population grows and life expectancies continue to increase, degenerative diseases of the bones, muscles, and connective tissue are a growing problem for society. Current therapies for osteodegenerative disorders such as hormone replacement therapies, calcium/vitamin D supplements and oral bisphosphonates are often inadequate to stop degeneration and/or have serious negative side effects. Thus, there is an urgent need in the medical community for more effective and safer treatments. Stem cell therapies for osteodegenerative disorders have been rigorously explored over the last decade and are yielding some promising results in animal models and clinical trials. Although much work still needs to be done to ensure the safety and efficacy of these therapies, stem cells represent a new frontier of exciting possibilities for bone and cartilage regeneration.
Subject
Embryology,Biomedical Engineering
Reference120 articles.
1. Office of the Surgeon General (US). Bone Health and Osteoporosis: a Report of the Surgeon General. Reports of the Surgeon General, MD, USA (2004 ).
2. Kanis JA. WHO Technical Report: Assessment of Osteoporosis at the Primary Health-care Level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK, 66 (2007).
3. Why do geriatric outpatients have so many moderate and severe vertebral fractures? Exploring prevalence and risk factors
4. Revision Hip Replacement in Patients 55 Years of Age and Younger
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献